Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5409-5415

  Karras, James G ^a   McGraw, Kathy ^a   McKay, Robert A ^a   Cooper, Scott R ^a   Lerner, Dmitri ^a   Lu, Tao ^a   Walker, Christoph ^b   Dean, Nicholas M ^a   Monia, Brett P ^a  

^a ISIS PHARMACEUTICALS   (United States)

^b NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTERLEUKIN 5;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHILIA; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

EID: 0034658410     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5409     Document Type: Article

References (51)

1. Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422.
2. Khalife, J., M. Capron, J. Y. Cesbron, P. C. Tai, H. Taelman, L. Prin, and A. Capron. 1986. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. J. Immunol. 137:1659.
3. Abu-Ghazaleh, R. I., T. Fujisawa, J. Mestecky, R. A. Kyle, and G. J. Gleich. 1989. IgA-induced eosinophil degranulation. J. Immunol. 142:2393.
4. Kroegel, C., T. Yukawa, G. Dent, P. Venge, K. F. Chung, and P. J. Barnes. 1989. Stimulation of degranulation from human eosinophils by platelet-activating factor. J. Immunol. 142:3518.
5. Durham, S. R., and A. B. Kay. 1985. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin. Allergy 15:411.
6. Wardlaw, A. J., S. Dunnette, G. J. Gleich, J. V. Collins, and A. B. Kay. 1988. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma: relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62.
7. Diaz, P., M. C. Gonzalez, F. R. Galleguillos, P. Ancic, O. Cromwell, D. Shepherd, S. R. Durham, G. J. Gleich, and A. B. Kay. 1989. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am. Rev. Respir. Dis. 139:1383.
8. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffrey, D. J. Quint, and A. B. Kay. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541.
9. Robinson, D. S., S. Ying, A. M. Bentley, Q. Meng, J. North, S. R. Durham, A. B. Kay, and Q. Hamid. 1993. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92:397.
10. Bentley, A. M., Q. Meng, D. S. Robinson, Q. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35.
11. Robinson, D. S., Q. Hamid, S. Ying, A. Bentley, B. Assoufi, S. Durham, and A. B. Kay. 1993. Prednisone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am. Rev. Respir. Dis. 148:401.
12. Limaye, A. P., J. S. Abrams, J. E. Silver, E. A. Ottesen, and T. B. Nutman. 1990. Regulation of parasite-induced eosinophilia: selectively increased interleukin-5 production in helminth-infected patients. J. Exp. Med. 172:399.
13. Owen, W. F., M. E. Rothenberg, J. Petersen, P. F. Weller, D. Silberstein, A. L. Sheffer, R. L. Stevens, R. J. Soberman, and K. F. Austen. 1989. Interleukin-5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J. Exp. Med. 170:343.
14. Owen, W. F., J. Petersen, D. M. Sheff, R. D. Folkerth, R. J. Anderson, J. M. Corson, A. L. Sheffer, and K. F. Austen. 1990. Hypodense eosinophils and interleukin-5 activity in the blood of patients with the eosinophilia-myalgia syndrome. Proc. Natl. Acad Sci. USA 87:8647.
15. Coffman, R. L., B. W. Seymour, S. Hudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:308.
16. Okudaira, H., M. Nogami, G. Matsuzaki, M. Dohi, M. Suko, S. Kasuya, and K. Takatsu. 1991. T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5. Int. Arch. Allergy Appl. Immunol. 94:171.
17. Tominaga, A., S. Takaki, N. Koyama, S. Katoh, R. Matsumoto, M. Migita, Y. Hitoshi, Y. Hosoya, S. Yamauchi, and Y. Kanai. 1991. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin-5) develop eosinophilia and autoantibody production. J. Exp. Med. 173:429.
18. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15.
19. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195.
20. Yoshida, T., K. Ikuta, H. Sugaya, K. Maki, M. Takagi, H. Kanazawa, S. Sunaga, T. Kinashi, K. Yoshimura, J. Miyazaki, et al. 1996. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5Rα-deficient mice. Immunity 4:483.
21. Lee, H. J., N. Koyano-Nakagawa, Y. Naito, J. Nishida, N. Arai, K. Arai, and T. Yokota. 1993. cAMP activates the IL-5 promoter synergistically with phorbol ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4. J. Immunol. 151:6135.
22. Monia, B. P., E. A. Lesnik, C. Gonzalez, W. F. Lima, D. McGee, C. J. Guinosso, A. M. Kawasaki, P. D. Cook, and S. M. Freier. 1993. Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268:14514.
23. Altmann, K.-H., N. M. Dean, D. Fabbro, S. M. Freier, T. Geiger, R. Haner, D. Husken, P. Martin, B. P. Monia, M. Muller, et al. 1996. Second generation of antisense oligonucleotides: from nuclease resistance to biological efficacy in animals. Chimia 50:168.
24. Dean, N. M., and R. H. Griffey. 1997. Identification and characterization of second-generation antisense oligonucleotides. Antisense Nucleic Acid Druy Dev. 7:229.
25. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysomography. Am. J. Respir. Crit. Care Med. 156:766.
26. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretsky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546.
27. DeMonchy, J. G., H. F. Kauffman, P. Venge, G. H. Koeter, H. M. Jansen, H. J. Sluiter, and K. De Vries. 1985. Bronchoalveolar eosinophilia during antigen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373.
28. Gibson, P. G., P. J. Manning, P. M. O'Byrne, A. Girgis-Gabardo, J. Dolovich, J. A. Denburg, and F. E. Hargreave. 1991. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils and their progenitors. Am. Rev. Respir. Dis. 143: 331.
29. Hutson, P. A., M. K. Church, T. P. Clay, P. Miller, and T. Holgate. 1988. Early and late-phase bronchoconstriction after antigen challenge of nonanesthetized guinea pigs. I. The association of disordered airway physiology with leukocyte infiltration. Am. Rev. Respir. Dis. 137:548.
30. Ishida, K., R. J. Thompson, L. L. Beattie, B. Wiggs, and R. R. Schellenberg. 1990. Inhibition of antigen-induced airway hyperresponsiveness but not acute hypoxia or airway eosinophilia, by an antagonist of platelet-activating factor. J. Immunol. 144:3907.
31. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin-4, but not interleukin-5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109.
32. Hogan, S. P., K. I. Matthaei, J. M. Young, A. Koskinen, I. G. Young, and P. S. Foster. 1998. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol. 161:1501.
33. Drazen, J. M., J. P. Arm, and K. F. Austen. 1996. Sorting out the cytokines of asthma. J. Exp. Med. 183:1.
34. Kung, T. T., D. M. Stelts, J. A. Zurcher, G. K. Adams, 3rd, R. W. Egan, W. Kreutner, A. S. Watnick, H. Jones, and R. W. Chapman. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Respir. Cell. Mol. Bio. 13:360.
35. Hamelmann, E., A. Oshiba, J. Loader, G. L. Larsen, G. Gleich, J. Lee, and E. W. Gelfand. 1997. Anti-interleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am. J. Respir. Crit. Care Med. 155:819.
36. Van Oosterhout, A. J., A. R. Ladenius, H. F. Savelkoul, I. Van Ark, K. C. Delsman, and F. P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147:548.
37. Egan, R. W., D. Athwahl, C. C. Chou, R. W. Chapman, S. Emtage, C. H. Jenh, T. T. Kung, P. J. Mauser, N. J. Murgolo, and M. W. Bodmer. 1997. Pulmonary biology of anti-interleukin-5 antibodies. Mem. Inst. Oswaldo Cruz 92(Suppl. 2): 69.
38. Nyce, J. W., and W. J. Metzger. 1997. DNA antisense therapy for asthma in an animal model. Nature 385:721.
39. Hogan, S. P., A. Koskinen, and P. S. Foster 1997. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol. Cell Biol. 75:284.
40. Shardonofsky, F. R., J. Venzer III, R. Barrios, K.-P. Leong, and D. P Huston. 1999. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma. J. Allergy Clin. Immunol. 104:215.
41. 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J. Pharmacol. Exp. Ther. 267:1181.
42. Butler, M., K. Stecker, and C. F. Bennett. 1997. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues. Lab. Invest. 77:379.
43. Kreig, A. M., F. Gmelig-Meyling, M. F. Gourley, W. J. Kisch, L. A. Chrisy, and A. D. Steinberg. 1991. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res. Dev. 1:161.
44. Kronenwett, R., U. Steidl, M. Kirsch, G. Sczakeil, and R. Haas. 1998. Oligode-oxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset. Blood 91:852.
45. Molet, S., D. Ramos-Barbon, J. G. Martin, and Q. Hamid. 1999. Adoptively transferred late allergic response is inhibited by IL-4, but not IL-5, antisense oligonucleutides. J. Allergy Clin. Immunol. 104:205.
46. Denburg, J. A., J. E. Silver, and J. S. Abrams. 1991. Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood hasophil-eosinophil progenitors. Blood 77: 1462.
47. Lopez, A. F., M. F. Shannon, M.-M. Chia, L. Park, and M. A. Vada. 1992. Regulation of human eosinophil production and function by interleukin-5. Immunol. Ser. 57:549.
48. Clutterbuck, E., J. G. Shields, J. Gordon, S. H. Smith, A. Boyd, R. E. Callard, H. D. Campbell, I. G. Young, and C. J. Sanderson. 1987. Recombinant human interleukin-5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur. J. Immunol. 17:1743.
49. Morikawa, K., F. Oseko, S. Morikawa, K. Imai, and M. Sawada. 1993. Recombinant human IL-5 augments immunoglobulin generation by human B lymphocytes in the presence of IL-2. Cell. Immunol. 49:390.
50. Bertolini, J. N., C. J. Sanderson, and E. M Benson. 1993. Human interleukin-5 induces staphylococcal A Cowan 1 strain-activated human B cells to secrete IgM. Eur. J. Immunol. 23:398.
51. Huston, M. M., J. P. Moore, H. J. Mettes, G. Tavana, and D. P. Huston. 1996. Human B cells express IL-5 receptor messenger ribonucleic acid and respond to IL-5 with enhanced IgM production after mitogenic stimulation with Moraxella catarrhalis. J. Immunol. 156:1392.